Showing 1 - 6 results of 6 for search 'A. Al-Kali', query time: 0.04s Refine Results
  1. 1
    P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017

    P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017 by N. Mclaughlin, G. Ruan, K. Wudhikarn, A. Al-Kali, A. Tefferi, N. Gangat, R. Go, M. Patnaik, M. Shah

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS

    P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS by I. Johnson, K. McCullough, F. Farrukh, A. Al-Kali, H. Alkhateeb, K. Begna, A. Mangaonkar, M. Litzow, W. Hogan, M. Shah, M. Patnaik, A. Pardanani, A. Tefferi, N. Gangat

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER

    P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER by H. Audil, M. Shah, K. Rabe, W. Ding, P. Hampel, N. N. Bennani, T. Call, C. Hanson, Y. Wang, A. Koehler, S. Schwager, J. Leis, S. Slager, S. Kenderian, A. Al-Kali, G. Nowakowski, M. Shi, S. Parikh

    Published 2022-06-01
    Get full text
    Article
  4. 4
    European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

    European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response by K. H. Begna, J. Kittur, N. Gangat, H. Alkhateeb, M. S. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, A. Pardanani, C. A. Hanson, R. P. Ketterling, A. Tefferi

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”

    Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” by K. H. Begna, X. Xu, N. Gangat, H. Alkhateeb, M. M. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, C. C. Hook, A. P. Wolanskyj-Spinner, A. Mangaonkar, R. He, A. Pardanani, M. Shah, R. P. Ketterling, A. Tefferi

    Published 2022-04-01
    Get full text
    Article
  6. 6
    P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYELOID CLINICAL TRIAL PROGRAM

    P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYEL... by A. M. Zeidan, A. Al-Kali, U. Borate, T. Cluzeau, A. E. DeZern, J. Esteve, A. Giagounidis, K. Kobata, R. Lyons, U. Platzbecker, D. A. Sallman, V. Santini, G. F. Sanz, M. A. Sekeres, A. H. Wei, Z. Xiao, M. Van Hoef, C. Nourry-Boulot, I. Sadek, F. Ma, A. Iordan, J. Sabo, G. Garcia-Manero

    Published 2022-06-01
    Get full text
    Article

Search Tools: